This study was initiated to examine the effects of caffeine on the DNA damage response (DDR) and homologous recombination (HR). An initial 2 h exposure to 5 mM caffeine slowed a fraction of the cells in G1, but thereafter, continued caffeine exposure permitted this cell fraction to progress through the cycle until they eventually stalled at G2/M and underwent apoptosis. This prolonged caffeine exposure also induced a strong DDR along with subsequent activation of wild-type p53 protein. An unexpected observation was the caffeine-induced depletion of Rad51 (and Brca2) proteins. Consequently, caffeine-treated cells were expected to be inefficient in HR. However, a dichotomy in the HR response of cells to caffeine treatment was revealed. Caffeine treatment rendered cells significantly better at performing the nascent DNA synthesis that accompanies the early strand invasion steps of HR. Conversely, the increase in nascent DNA synthesis did not translate into a higher level of gene targeting events. Levels of Rad51 appear to be irrelevant. Thus, prolonged caffeine exposure stalls the cell cycle, induces a p53-mediated apoptotic response and a down-regulation of critical HR proteins, and stimulates early steps of HR, but not the formation of complete repair products.
These studies have lent valuable insight into the response of tumour-like cells to caffeine treatment.
The United States Food and Drug Administration (FDA) has regulated the use of caffeine in food since 1958 (24) . Recently, there have been moves to re-evaluate the safety of caffeine in light of the increase in the number of products, and in the popularity of caffeine-containing energy products and their use by children and adolescents (24) . Reports also suggest that a significant number of individuals consume more than the commonly cited health reference value of 400 mg/d for healthy adults (25) . More concerning however, is the popularity of pure caffeine powder among youth and exercise enthusiasts, and with at least 2 deaths attributed to its use, the FDA has posted a warning on their website about powdered pure caffeine (www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm405787.htm).
Further understanding the effects of caffeine on mammalian cells is of importance from a health and consumer perspective, and of interest to us was to examine how caffeine affects mammalian DNA repair processes and particularly, HR. Our cell system affords a unique opportunity to study the effects of caffeine in the background of a wild-type p53 gene (26) . At the outset of this study, we sought to use caffeine as an inhibitor of the ATM/ATR phosphorylation cascades (4) (5) (6) (7) . Indeed, up until approximately 4 hours of exposure, caffeine appears to act as an inhibitor. Quite unexpectedly, we observed that with prolonged exposure, caffeine induced a strong DDR response along with subsequent activation of p53 in the absence of any additional DNA damage. Examination of caffeine effects on the cell cycle revealed that a 2 h exposure to 5 mM caffeine slows a fraction of the cells in G1, but thereafter, continued caffeine exposure permitted this fraction of cells to progress through the cell cycle to the G2/M checkpoint, whereupon cell division was halted and the cells underwent apoptosis. An additional revelation was that caffeine treatment triggered the depletion of two critical HR proteins, Rad51 and Brca2, after as little as 30 minutes of exposure. Thus, we fully expected caffeine-treated cells to be inefficient in the nascent DNA synthesis that accompanies the early homology search and strand invasion steps of HR in vivo. However, contrary to expectation, caffeine-treated cells performed the early steps of HR significantly better than untreated cells. We attributed this stimulatory effect to partial synchronization that permits a larger fraction of the cells to be in a stage permissive for nascent DNA synthesis and an increase in the frequency of HR/cell (hyperrecombination). We subsequently verified this hypothesis with cells that were siRNA-depleted for Rad51 (and Brca2). Additionally, a dichotomous effect of caffeine on HR was revealed;
caffeine-treated cells were unable to translate the increase in nascent DNA synthesis into gene targeting products. Because only one gene targeting event is usually permitted per cell (27) , this observation further supports a hyper-recombination model. Levels of Rad51 appear to be irrelevant. Increased accessibility of the target locus following caffeine treatment may be one mechanism by which cells with severely depleted HR proteins become hyper-recombinogenic.
MATERIALS AND METHODS

Cell lines and culture conditions
The origins of the igm482 hybridoma and its derivatives, WT5 expressing N-terminal 3X FLAGtagged wild-type mouse Rad51, Rad51 knockdown #10 stably expressing siRNAs to mouse Rad51, and p53 knockdowns #3 and #6 stably expressing siRNAs to mouse p53, have been described (26, 28, 29) . Hybridoma igm482 was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 13% bovine calf serum, penicillin/streptomycin and 2-mercaptoethanol as described (28, 30) and the selectable agents hygromycin and puromycin were included as required (26) . HeLa and Chinese hamster ovary (CHO-WBL) cells were obtained from the American Type Culture Collection (ATCC). HeLa cells were maintained in DMEM with 10% fetal bovine serum, penicillin/streptomycin and 2-mercaptoethanol, while CHO-WBL cells were maintained in McCoy's 5A medium supplemented with 10% fetal bovine serum and penicillin/streptomycin. All cell lines were grown in a humidified 7% CO 2 atmosphere at 37 °C.
Inhibitors
Stock solutions used included 77 mM caffeine (Sigma) in DMEM media; 10 mM Ku55993 (Selleck Chemicals) in dimethyl sulfoxide (DMSO); 10 mM VE-821 (Selleck Chemicals) in DMSO; 10 mM MG-132 (Calbiochem) in DMSO.
Cell cycle analysis
Caffeine-treated or untreated cells were fixed in ice-cold 70% ethanol, washed with phosphatebuffered saline and stained with propidium iodide (50 μg/ml, Sigma) at room temperature for 60 min in the presence of RNase (100 μg/ml, Sigma) (31) . Cell cycle analysis was performed using fluorescence-activated cell sorting (FACS) with a Beckman Coulter Cytomics FC 500MPL. For each determination, a minimum of 15,000 cells were analyzed using MXP cytometer software.
Apoptosis Assay
An apoptosis (caspase activity) assay was performed as described previously (32) . In brief, cell extracts were prepared as described except that 1 mM DTT was included in the lysis buffer.
Extracts were mixed with reaction buffer containing Ac-DEVD-AMC, a fluorogenic substrate specific for caspase-3 (BIOMOL Research Laboratories, Inc.). The liberation of the fluorescent AMC at 37°C was measured every two minutes for one hour using a BIO-TEK FLx800 microplate fluorescence reader (Ex 380/20nm, Em 460/40nm). The slope and protein concentration were used to calculate a relative DEVDase activity/min/µg protein for each sample.
Protein and RNA analysis
Western blot analysis was performed as described previously (33) recommended by the manufacturer (GE Healthcare). India ink staining was performed as described (34) .
RT-PCR was performed as previously described (33) . Primers specific for RT-PCR analysis of immunoglobulin µ, p53, p21, Rad51 and Brca2 transcripts have been described (26, 33) . Densitometric analysis of band intensity for RT-PCR utilized BioRad Gel Doc instrumentation and Quantity One imaging software (Version 4.4.6, BioRad).
Homologous recombination assays
The formation of nascent DNA that follows the strand invasion event of HR (3' polymerization) was measured by PCR as described previously (35) , except that 4 x 10 7 cells were treated with 5 mM caffeine for 2 hours prior to electroporation with 100 µg of linearized vector. Cells were resuspended in regular growth media or in growth media with supplemented with 5mM caffeine.
The intensity of specific PCR bands was quantified by densitometric analysis using BioRad Gel Doc instrumentation and Quantity One imaging software (Version 4.4.6, BioRad). The measurement of gene targeting was performed as described previously (27) .
General DNA techniques
Plasmid DNA was propagated in Escherichia coli (DH5α) and extracted using the PureLink™ HiPure plasmid maxiprep kit (Life Technologies). Restriction enzymes were purchased from New England BioLabs (Mississauga, Ontario) and used in accordance with manufacturer instructions.
Statistical analysis
Statistical analysis was performed by one-way analysis of variance (ANOVA) and Tukey's-HSD test, or t-test using VassarStats software available online (http://vassarstats.net/). Significance was assessed at p ≤ 0.05. Error bars represent the standard error of the mean.
RESULTS
Caffeine initially suppresses, then activates, the DNA damage response
To investigate the effect of caffeine on the DNA damage response (DDR), a time-course of caffeine treatment along with Western blot analysis of relevant DDR proteins was performed in the mouse hybridoma cell line, igm482 (28,30) ( Figure 1A ). The igm482 hybridoma cells express a wild-type p53 gene (26) permitting analysis of caffeine effects on wild-type p53
responses. As shown in panel 1, levels of endogenous wild-type p53 protein were initially reduced up to the 4 h time point, but thereafter, p53 protein levels accumulated significantly.
Using anti-human phosphoSer15-p53 antibody (Abcam), which cross-reacts with the equivalent mouse phosphoSer18-p53 (36), we observed that caffeine initially caused a decrease in the level of activated phosphoSer18-p53 (panel 2), but after approximately 8 h of caffeine treatment, the phosphorylation of mouse p53 at Ser18 was induced. We also note the formation of phosphoChk1 protein (panel 3) (a marker of ATR activation) and phospho-Chk2 protein (panel 4) (a marker of ATM activation), and an increase in p21 protein (panel 5) whose expression is controlled by activated p53. Thus, these results are consistent with an initial caffeine-induced suppression, followed by activation, of the ATM/ATR kinases along with subsequent activation/stabilization of p53 after approximately 8 h of caffeine treatment (3, 37) . In contrast to the marked changes in the proteins discussed above, -actin levels remained relatively consistent (panel 6) suggesting that caffeine does not induce general changes in protein levels over the 24 h period examined.
Further support for caffeine-induced changes to the ATM/ATR activation of p53 is provided by the ATM and ATR inhibitors, Ku55993 and VE-821, respectively (38,39) ( Figure   1B As indicated above, caffeine exposure initially results in a reduction in the levels of p53
protein, but thereafter, p53 protein accumulates ( Figure 1A , panels 1 and 2). To determine whether these changes were due to p53 gene expression or to protein stability, we first examined the levels of p53 gene expression through RT-PCR analysis using the level of the single copy, chromosomal immunoglobulin µ mRNA as a reference. There were no changes in the level of p53 mRNA at 0, 2, 4 or 8 h of 5 mM caffeine treatment (data not shown) and as shown in Figure   1C , this steady-state level of p53 mRNA persisted up to 24 h. We then exposed the hybridoma cells to 5 mM caffeine for 2 h with the proteasome inhibitor MG132 (40) . As shown in Figure   1D , the combination of caffeine and MG-132 (lane 3) and MG132 alone (lane 4), result in a comparable accumulation of p53 protein, supporting the conclusion that the initial drop in p53
observed after 2 h caffeine exposure (lane 2) is due to proteasome-mediated degradation (41) .
After approximately 4-8 h of treatment, p53 levels begin to steadily increase presumably due to ATM/ATR activation of a caffeine-induced DDR which is likely responsible for p53 stabilization via phosphoSer18-p53 formation (3).
Caffeine exposure induces cell cycle arrest and cell death
The effect of various concentrations of caffeine on the growth of hybridoma cells is presented in Figure 2A . There was little difference in growth between untreated hybridoma cells and those exposed to 0.5 mM caffeine. A reduction in growth was observed after 24 h of 1 mM caffeine treatment. However, at caffeine concentrations of 2 mM and higher, growth ceased and cell death was evident.
Caffeine has been reported to promote cell cycle arrest and apoptosis (10) . To examine this, we performed cell cycle analysis using propidium iodide staining and FACS (31) . To determine the number of cells in each phase of the cell cycle (G1, S/G2, >4N), gate analysis was applied using MXP cytometer software. This experiment was performed on five independent occasions with untreated hybridoma cells. Statistical analysis determined that the assay is highly reproducible and the standard error of the mean ranged from 2-5% for each cell cycle phase (data not shown). We then exposed the hybridoma cells to 5 mM caffeine for 24 h and repeated the analysis. As shown in Figure 2B , and summarized in Figure 2C , untreated (UT) hybridoma cells displayed approximately 45% of cells in G1 and close to 50% in S/G2 with approximately 20% of these in G2 (in Figure 2C , this subset is contained within brackets). After 24 h caffeine treatment, less than 20% of the cells were in G1 and the proportion of cells in G2 had increased to approximately 35%. There was also a sizable increase in the fraction of cells in which the DNA content was >4N (from approximately 7% in UT to approximately 20% after 24 h caffeine treatment), and an increase in the number of apoptotic cells. Since the cells are clearly unable to divide (Figure 2A ), the results suggest that 24 h of 5 mM caffeine treatment induces a strong G2/M checkpoint arrest (42) . To investigate whether the visible decline in viable hybridoma cells/ml at caffeine concentrations ≥ 2mM resulted from true apoptosis, a fluorogenic assay using the aminomethylcoumarin (AMC)-conjugated caspase-3 substrate Av-DEVD-AMC, was used to monitor caspase-3 activation, a marker of apoptotic activity (43) . As shown in Figure 2D , a 24 h treatment with 5 mM caffeine elicits a significant apoptotic response. Based on the above evidence, we conclude that a 24 h treatment with ≥ 5 mM caffeine induces G2/M arrest and initiates apoptotic death.
Endogenous Rad51 and Brca2 proteins are depleted by caffeine treatment
Given the role of the DDR in DNA repair, we were interested in whether caffeine treatment affected the levels of critical HR proteins. Mouse hybridoma cells were exposed to a range of caffeine concentrations for 0, 4, 8, 16 and 24 h following which whole cell extracts were prepared and endogenous levels of Rad51 protein were examined by Western blot analysis. As shown in Figure 3A , a decrease in the cellular concentration of Rad51 protein was observed after 4 h following treatment with caffeine at concentrations as low as 1-2 mM, but thereafter, Rad51 levels recover. However, at caffeine concentrations of 5 mM and 10 mM, more abrupt decreases in Rad51 protein were apparent beginning at the earliest 4 h time point, with continued decline until treatment end at 24 h.
To determine the generality of this effect, we repeated the 24 h exposure to 5 mM caffeine using several different cell types ( Figure 3B ). Western blot analysis confirmed that caffeine treatment depletes endogenous Rad51 levels in igm482 mouse hybridoma cells (lanes following caffeine treatment in this study.
To further elucidate how caffeine affected Rad51 protein levels over time, we first performed a time course exposure to 5 mM caffeine on WT5. As shown in Figure 3C (panel 1), levels of FLAG-Rad51 initially drop upon exposure to 5 mM caffeine, but after approximately 8 h, they begin to recover and eventually increase above untreated levels. This excess wild-type FLAG-Rad51 does not change the way that ATM/ATR in WT5 react to caffeine as evidenced by the initial decrease in wild-type p53 and phosphoSer18-p53 followed by their accumulation beginning at approximately 8 h (panels 2,3). These responses mirror those of igm482 ( Figure   1A ).
Previously, we showed that levels of Rad51 and Brca2 are dependent on each other (26) .
Therefore, we wondered whether the reduced levels of endogenous Rad51 protein in caffeinetreated igm482 cells had a concomitant effect on the levels of endogenous Brca2 protein.
To ascertain this, we repeated a time course exposure to 5 mM caffeine and conducted Western blot analyses of both Rad51 and Brca2 protein in igm482. As shown in Figure 3D To further investigate the mechanism behind the reduced levels of endogenous Rad51
(and Brca2) proteins upon caffeine treatment, we utilized RT-PCR to examine the effect of 5 mM caffeine on Rad51 and Brca2 mRNA levels in igm482, with the results being standardized relative to expression of the single copy immunoglobulin µ gene. At 0, 2, 4 and 8 h of 5 mM caffeine exposure, mRNA levels of both Rad51 and Brca2 were unchanged ( Figure 3E ).
However, after 24 h the Rad51/µ and the Brca2/µ ratios were reduced. p53 has been reported to down-regulate Rad51 and Brca2 expression (47, 48) , and this mechanism could be involved beginning at approximately 4-8 h when the DDR is activated and p53 levels begin to rise.
However, it is noteworthy that CHO-WBL cells express a p53 gene that is not induced by DNA damage (22) yet still exhibit a marked caffeine-induced depletion of Rad51. A similar decline is observed in HeLa cells that normally express low levels of wild-type p53 due to the presence of viral HPV E6 proteins that target p53 for degradation (49, 50) .
To explore whether elevated p53 levels might be down-regulating Rad51 (and Brca2) upon prolonged caffeine treatment in our hybridoma cell lines, we utilized igm482 derivatives stably knocked down for wild-type p53 with the anticipation that such cells would display a less proficient DDR response upon caffeine treatment. Two knockdown (KD) cell lines, p53 KD #3
and p53 KD #6 bear approximately 30% and 65% residual p53, respectively (26) . As expected, repeat blots (not shown), densitometry was performed and average Rad51/p53 ratios were calculated. If p53 levels were directly correlated with reduced Rad51 levels, we would expect the Rad51/p53 ratios to be equivalent in all cell lines. Our results indicate that the ratios in the p53 knockdown lines are approximately 2-fold higher than igm482. This further suggests that the mechanism responsible for reduced Rad51 is most likely due to more complex, p53-independent regulation.
In summary, the above evidence indicates that initially, the caffeine-induced depletion of Rad51, and Brca2 (in igm482), is at the protein level as supported by the steady-state levels of endogenous Rad51 and Brca2 mRNA, and by the depletion of Rad51 protein from genes driven by 2 different promoters (endogenous Rad51 promoter and CMV-FLAG-Rad51). However, after approximately 8 h caffeine treatment, the mechanism becomes one that involves at least in part (p53-independent) transcriptional control. This is evidenced by the decline of both Rad51
and Brca2 mRNA in igm482, and the gross reduction of Rad51 in cells with compromised p53
including CHO-WBL cells, HeLa cells and our p53 knockdown cell lines.
Elevated HR activity in caffeine-treated cells
Given that Rad51 and Brca2 are both crucial to HR, we fully expected to observe reduced HR in caffeine-treated cells as has been reported previously (for example, [17] [18] [19] 21) . To examine this, we exploited our 3' polymerization assay (35) , which detects nascent DNA synthesis from the 3' ends of linearized, gapped, transfected plasmid DNA, a process that accompanies and relies upon the early homology search and strand invasion steps of HR in vivo. Previously, we showed that normal levels of endogenous Rad51 and Brca2 proteins are required for efficient 3'
polymerization (26, 51) . Therefore, we investigated whether caffeine exposure and the ensuing depletion of Rad51 (and Brca2) ( Figure 3D ) would result in a lower efficiency of 3'
polymerization. In preliminary experiments, we attempted to assess 3' polymerization after 24 h exposure to 5 mM caffeine. However, at this time point, the cells are dying ( Figure 2 ) and following electroporation, cell survival is so low (<5%) that an insufficient number of viable cells remains to perform the assay (data not shown). Consequently, we examined postelectroporation cell survival over a time course exposure to 5 mM caffeine and determined that a 2 h caffeine treatment, followed by electroporation, produced a level of cell survival suitable for the experiment. This outcome was acceptable because at 2 h of caffeine exposure, endogenous Rad51 and Brca2 levels are noticeably depleted ( Figure 3D ). To ensure the continued depletion of the HR proteins, we re-suspended caffeine-treated cells that had been electroporated with the linearized, gapped vector, in growth medium supplemented with 5mM caffeine for the duration of the experiment.
Quite unexpectedly, caffeine-treated igm482 cells feature a significantly higher peak frequency of 3' polymerization, compared to untreated cells, which represents an average 5.5-fold increase ( Figure 4A ). The frequency of 3' polymerization in caffeine-treated cells remains significantly higher at the 9 h time point as well ( Figure 4A ). Caffeine treatment does not appear to change the 3' polymerization kinetics profile, characteristic of igm482 (data not shown) (35) .
As shown in Figure 2B , a 24 h caffeine exposure generates an increased fraction of cells that are stalled at the G2/M boundary or have undergone re-replication without cell division (>4N).
Therefore, we reasoned that the enhanced 3' polymerization frequency in caffeine-treated cells might be the result of these cells accumulating in the permissive stage for 3' polymerization.
Consequently, we re-visited the cell cycle analysis of caffeine-exposed cells in a time-course experiment, to mirror the post-electroporation measurements of 3' polymerization ( Figure 4B ).
The results are further summarized in Figure 4C . A 2 h caffeine exposure resulted in an increase in the fraction of G1 phase cells, but thereafter, we observed a decrease in the proportion of G1 phase cells in favor of a steady increase in non-G1 phase cells (S, G2 and >4N) until eventually, after 11 h of caffeine treatment (9 h, 3' polymerization measurement), they reached a state similar to that observed after 24 h caffeine exposure ( Figure 2B ). Thus, while caffeine exposure decreases the cellular content of Rad51 (and Brca2), it also appears to slow the cell cycle ultimately permitting a fraction of G1 phase cells to move in bulk into the stage permissive for 3'
polymerization. The significant peak in 3' polymerization in caffeine-treated cells at 6 h ( Figure   4A ) correlates with the increasing content of S/G2 phase cells at 8 h of caffeine treatment ( Figure   4B and C). However, despite increasing S/G2 phase cells, 3' polymerization is declining at 9 h, consistent with plasmid degradation (35) .
Previously, we showed that stable siRNA knockdown of endogenous Rad51 or Brca2 in asynchronously-dividing cells reduces the efficiency of 3' polymerization (26, 51) . However, the above result predicts that 3' polymerization might be enhanced in caffeine-exposed Rad51-knockdown cells. To test this, the Rad51-knockdown cell line KD#10 (bearing approximately 40% residual Rad51)(26) was treated with 5 mM caffeine in the same manner described above, and examined in the 3' polymerization assay. Compared to untreated KD#10 cells, caffeine treatment significantly increased the peak frequency of 3' polymerization by approximately 3-fold ( Figure 4D ). This increase essentially corrects the 3' polymerization deficit in the KD#10 cells (26) . Thus, in an untreated, asynchronous cell population, low Rad51 levels reduce 3'
polymerization, but if cells with low Rad51 levels are treated with caffeine and permitted to progress through the cell cycle in relative synchrony resulting in more cells entering the phase proficient for 3' polymerization, the frequency of 3' polymerization is enhanced.
The effect of brief caffeine treatment is reversible and still elevates HR
Having established that continued caffeine exposure causes activation of the DDR and a G2/M block and yet despite low Rad51 levels, generates a spike in 3' polymerization frequency ( Figure   4 ), we endeavored to examine the effects of a short 2 h caffeine treatment (which depletes Rad51
and Brca2, but does not activate the DDR). To assess the Rad51 status and DDR under these circumstances, a time course measurement of protein levels was performed ( Figure 5A lanes 3-7) . Furthermore, activated p53 levels were initially decreased (panel 3, lane 2), as seen previously, and were never stimulated by this reversible 2 h caffeine treatment (panels 2 and 3).
Previous cell cycle analyses had revealed that a 2 h caffeine exposure results in ~65% of cells in G1 compared to ~45% G1 phase cells in an untreated population ( Figure 4C ). Figure 5B presents further cell cycle analyses, which are summarized in Figure 5C . These results indicate that release into caffeine-free medium circumvents a G2/M block and the fraction of cells that were held in G1, move through the cell cycle. After 9 h, the cell cycle profile closely matches that of untreated cells (compare Figure 5B-9h and Figure 2B-UT) .
We then performed the 3' polymerization assay on these cells. Given that the levels of Rad51 had completely recovered after only 1 hour in caffeine-free media, we anticipated that we would see little or no effect of a 2 h caffeine treatment on 3' polymerization frequencies (measured at 3-9 h post-electroporation). However, based on our previous observation that cells moving in synchrony into a phase permissive for 3' polymerization might elevate the frequency of 3' polymerization, we acknowledged that the synchronous "release" of the additional 20% of cells stalled in G1 by a 2 h caffeine treatment, may elevate the frequency of 3' polymerization slightly. To our great surprise, our results indicate that cells treated with 5 mM caffeine for 2 h have a significantly higher peak frequency of 3' polymerization than untreated cells. This represents an average 10-fold increase at the peak ( Figure 5D ).
Thus, following a 2 h caffeine treatment, a fraction of cells with initially depleted, and now recovered Rad51 levels, progress in bulk into the permissive stage for 3' polymerization contributing to the spike in 3' polymerization observed.
Gene targeting is not stimulated in caffeine-treated cells
Finally, we tested whether the significant caffeine-induced increases in 3' polymerization would translate into higher frequencies of gene targeting. We have previously observed a consistent correlation between trends of 3' polymerization and gene targeting (26, 33) . Interestingly, as shown in Figure 6 , a 2 h caffeine treatment was not able to significantly increase gene targeting in igm482 cells, or in the Rad51 KD#10 cell line, despite the fact that substantial increases in 3' polymerization were observed with the same treatment in igm482 ( Figure 5D ). We hypothesized that perhaps the "additional" 3' polymerization events in these treated cell lines, could not be efficiently translated into gene targeting events, perhaps due to a rate-limiting amount of Rad51.
To answer this question, we treated WT5 with 5 mM caffeine for 2 hours. Our results suggest that caffeine can partially synchronize the cells and enhance nascent DNA synthesis during HR, but this effect does not translate into increased gene targeting. Rad51
does not appear to be the rate limiting factor in this reaction.
Illegitimate recombination is stimulated in caffeine-treated cells
To test whether non-homologous recombination was affected by caffeine-treatment, we measured the efficiency of illegitimate recombination (52) . We transfected plasmid DNA into untreated cells and cells that had been treated with 5 mM caffeine for 2 h, and those that were "pre-treated" with 5 mM caffeine and then maintained in 5 mM caffeine for 24 h postelectroporation. The experiment was repeated three times and each time, the transformation efficiency of caffeine-treated cells was higher than untreated cells. The mean fold increase in illegitimate recombination of the caffeine-treated cells over the three experiments was approximately 5-fold (data not shown).
DISCUSSION
A proficient DNA damage response (DDR) requires activated/stabilized wild-type p53 (37) through activation of the ataxia-telangiectasia mutated (ATM) and the AT-related (ATR)
proteins (53) (54) (55) . Our hybridoma cells express a wild-type p53 gene (26) and therefore, it was of interest to determine how caffeine affected the DDR in our system. Initially, caffeine appears to act as a suppressor of the ATM/ATR response, causing a decrease in p53 levels. However, prolonged exposure (greater than 4 h) to 5 mM caffeine strongly induces p53 activation/stabilization through formation of phosphoSer18-p53 along with phospho-Chk1 and phospho-Chk2, supporting activation of ATR and ATM kinases, respectively. Concomitant with the activation of wild-type p53, we also observed an increase of p21 protein, whose gene is a transcriptional target of activated p53. Abrogation of p53 activation following use of the ATM and ATR inhibitors, Ku55993 and VE-821 in conjunction with caffeine, provides additional support for caffeine-induced effects on this pathway. As predicted, our results showed that the changes in the p53 status of caffeine-treated cells was via alterations to protein stability, as evidenced by an increase in p53 levels upon treatment with a proteosome inhibitor at the 2 h treatment mark, and unchanged p53 mRNA levels.
A major role of the DDR is to delay cell cycle progression to allow time for repair of DNA damage. Based on our observations of caffeine-induced effects on the DDR, we subsequently examined the effects of caffeine on the cell cycle in our system. In the absence of polymerization (perhaps, S/G2) (35) . Previously, we showed that siRNA depletion of endogenous Rad51 reduces the frequency of 3' polymerization in a population of asynchronously-dividing cells (26) . However, given the caffeine-induced reduction in Rad51 and cell cycle dynamics described above, we wondered whether caffeine-treated, Rad51-knockdown cells would also be characterized by an enhancement in 3' polymerization. Indeed, this was the case providing further support for the notion that if cells with low Rad51 levels progress in bulk through the cell cycle into a phase conducive for 3' polymerization, the overall frequency of 3' polymerization is elevated. 3' polymerization frequencies were also increased in cells treated for 2 h and "released" into caffeine-free media. In this scenario, we imagine that the increased fraction of knockdown cells is compared with the peak 3' polymerization frequency of caffeine-treated igm482 cells (these two cell populations have comparably reduced levels of Rad51/Brca2), the increase in 3' polymerization frequency induced by caffeine is as much as 11-fold. This strongly suggests that caffeine treatment must trigger another mechanism that facilitates recombination, despite low Rad51 and Brca2 levels. Caffeine is known to induce changes to the accessibility of loci and has previously been reported to affect histone acetylation (68, 69) and chromatin condensation (70, 71) with consequences including increased DNA sensitivity to S 1 nuclease and increased ability to stain with acridine orange (70) , and increased accessibility of DNAse I (71).
Our results indicate that prolonged caffeine treatment triggers the DDR with activated p53 levels visible by 8 h. The link between the DDR and chromatin architecture is well established, with relaxed chromatin integral to DNA repair (72, 73) . A recent report (74) polymerization events described in this study bears transcriptional enhancers that regulate immunoglobulin locus accessibility and control IgH gene expression and class switch recombination (75) . In fact, the immunoglobulin µ heavy chain gene intronic enhancer is located within 8 kb of the µ gene sequences that are acquired by the invading 3' ends of the transfected, gapped vector. Given the caffeine-induced chromatin changes described above, it is not unreasonable to speculate that caffeine might also have more specific effects in enhancing IgH locus accessibility through unexpected changes in enhancer activity.
If one of the effects of caffeine is to disrupt chromatin, activate the DDR and thereby affect locus accessibility, this would predict an increase in illegitimate (non-homologous) recombination in caffeine-treated cells with wild-type p53. Indeed, our results suggest that illegitimate recombination is stimulated an average of approximately 5-fold upon caffeine treatment. Additionally, a recent report indicated that caffeine treatment induces an increase in unproductive interactions of the Rad51 nucleoprotein filament with non-homologous dsDNA (21) . This observation also supports an increase in illegitimate recombination in caffeine-treated cells. Accordingly, an increase in random integrations was observed upon caffeine treatment in the human fibrosarcoma cell line, HT1080, (which contains wild-type p53) (76) but not in ES cells (21) . Interestingly, non-homologous end joining (NHEJ) has been previously reported to be unaffected by caffeine-treatment in CHO cells (17, 77) . Taken together, these results support the hypothesis that in cells with wild-type p53, caffeine may indeed affect locus accessibility.
Gene targeting at the chromosomal immunoglobulin µ locus (27) The effects of caffeine on 3' polymerization and gene targeting described above were unexpected given the overwhelming negative effects of caffeine on recombination, which have been previously reported in bacteria, yeast and Drosophila (16) . In mammalian cells, caffeine is widely reported as a suppressor of HR, although the suggested mechanism of suppression varies.
Caffeine has been proposed to act by directly affecting HR, by inhibiting key activities of HR protein complexes, or by inhibiting upstream regulatory kinases or phosphatases (17, 18) . A more detailed molecular mechanism for caffeine's inhibition of HR has recently been reported (21) ; in vitro studies established that caffeine strongly reduced the efficiency of D-loop formation and caused unproductive interactions of the Rad51 nucleoprotein filament with non-homologous dsDNA, which resulted in inhibition of Rad51-catalyzed strand invasion. Caffeine therefore, was postulated to interfere with the critical early step of joint molecule formation by the Rad51-coated nucleoprotein filament, leading to the reduction in gene targeting observed (21) . Because the cell lines tested in the above studies express p53 that is unusual in its response to stress and DDR activation, we hypothesize that it is the DDR response and wild-type p53 gene of our cell lines that contribute to both the caffeine-induced increase in 3' polymerization, and the null effect of caffeine on gene targeting in our system.
Our results shed further light on the effects of caffeine on HR in mammalian cells with normal p53. We propose that caffeine treatment causes the rapid depletion of two critical HR proteins, Rad51 (and Brca2). However, the cell cycle effects (an initial slowing in G1, followed by an S/G2 block), and the onset of the DDR perhaps combined with loci-accessibility changes which occur concurrently, compensate for, and seemingly overcome, any negative effect of the reduction in HR protein levels. We see no evidence for an inhibitory effect of caffeine on the homology search and stand-invasion steps of HR, as suggested by stimulated frequencies of 3' polymerization in our caffeine-treated cell lines and we in fact propose that the cells may be hyper-recombinogenic.
Clearly, more studies are required to understand the association between caffeine exposure and recombination, especially given the varied nature of caffeine-induced responses in several cell types (10), the complexity associated with the p53 response and its regulatory network (37) and the effects of p53 on recombination (82). The results of our studies suggest that high doses of caffeine are highly toxic to mammalian cells and perturb HR. We have also unearthed a unique opportunity to further investigate how cells with compromised HR proteins (a feature of many tumour cells) can overcome HR defects. Differences in gene targeting frequencies between untreated and treated cells were determined by t-tests. All differences were non-significant (p≤ 0.05). Abbreviations: UT, untreated; T, treated.
